Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Didem Torumkuney und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Research Unit, GSK, London, UK. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Anti-Bacterial Agents, Haemophilus influenzae, Drug Resistance, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK.
Abstract (Originalsprache)
Objectives
To determine the antibiotic susceptibility of community-acquired respiratory tract infection (CA-RTI) Streptococcus pneumoniae and Haemophilus influenzae isolates from Italy and Spain, 2018–21.
Methods
MICs were determined by CLSI broth microdilution, and susceptibility data were interpreted using CLSI, EUCAST and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
Results
A total of 77 S. pneumoniae and 249 H. influenzae were collected from Italy and 176 S. pneumoniae and 275 H. influenzae from Spain. Approximately 65% of pneumococci were penicillin-susceptible by CLSI oral or EUCAST low-dose breakpoints; by EUCAST high-dose or CLSI intravenous administration, 92.2%/95.5% (Italy/Spain) were susceptible. In Italy, 71.4% to 89.6% susceptibility (CLSI) was observed to amoxicillin/clavulanic acid, amoxicillin and most cephalosporins. Cefaclor, tetracyclines, macrolides and trimethoprim/sulfamethoxazole were less active against Italian (51.9%–67.5% susceptible) versus Spanish (67.0%–81.2% susceptible) isolates. The most potent antibiotics were fluoroquinolones (≥99.4%, excluding EUCAST low-dose). Most H. influenzae isolates were β-lactamase negative with a few ampicillin-resistant isolates (CLSI: 0.5% Italy, 3.1% Spain). Rates of β-lactamase positivity were 14.1% (Italy) and 17.1% (Spain). Susceptibility was >90% (CLSI) except for ampicillin (82.7% Italy, 81.1% Spain) and trimethoprim/sulfamethoxazole (71.1% Italy, 68.0% Spain). Susceptibility by EUCAST was similar to CLSI, except for cefuroxime (82.3% Italy, 87.3% Spain susceptible, increased exposure versus 100% by CLSI).
Conclusions
Susceptibility of S. pneumoniae to many antibiotics was low in both countries, with susceptibility > 90% observed only with high-dose penicillin and fluoroquinolones (CLSI and EUCAST) and high-dose amoxicillin or amoxicillin/clavulanic acid (PK/PD). Higher susceptibility was seen with H. influenzae in both countries. Continued surveillance of antimicrobial resistance is important for guiding therapy of CA-RTIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Disease Research Unit, GSK, London, UK.
- Servicio de Microbiología, Hospital Universitario Ramon y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
- Department of Microbiology, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
- Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
- Chemical-Clinical and Microbiological Analysis, Azienda Socio-Sanitaria Territoriale (ASST) Grande Ospedale Metropolitano (GOM) Niguarda, Milano, Italy.
ORCID-Profile: Rafael Canton, Maurizio Sanguinetti
Förderung
- GSK
Zitieren
APA
Torumkuney, D., Canton, R., Pitart, C., Sanguinetti, M., Vismara, C., Farina, C., Sambri, V., Hawser, S., & Manoharan, A. (2025). Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf283
Vancouver
Torumkuney D, Canton R, Pitart C, Sanguinetti M, Vismara C, Farina C, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf283
BibTeX
@article{Torumkuney2025,
author = {Torumkuney, Didem and Canton, Rafael and Pitart, Cristina and Sanguinetti, Maurizio and Vismara, Chiara and Farina, Claudio and Sambri, Vittorio and Hawser, Stephen and Manoharan, Anand},
title = {Results from the Survey of Antibiotic Resistance (SOAR) 2018–21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf283}
}
EUVIMED